In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
Acromegaly is usually caused by a noncancerous tumor. Middle-aged adults are most commonly affected. Symptoms include enlargement of the face, hands, and feet. Prompt treatment is needed to avoid serious illness. Drugs can reduce the effects of growth hormone. If needed, surgery and radiation may be used to remove tumor cells.
In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
Today we begin a new series of feature articles that highlight the tireless work that people do to help others. Here are three amazing human beings: Jill Sisco runs the Acromegaly Community website and
Today we are starting a campaign to make sure all our readers diagnosed and living with acromegaly know their IGF-I levels. Make sure you ask your physician to tell you and please check your levels
In this podcast, Dr. Lewis Blevins discusses the medical management of acromegaly with the drug “pegvisomant for injection” or Somavert. This is our third podcast in a series of six on acromegaly and its management.
Our discussion today focuses on the results of our recent acromegaly survey. This survey was intended for those patients who have been diagnosed with acromegaly based on clinical biochemical and radiographic features.
In this podcast Dr. Blevins discusses aggressive pituitary tumors. Learn what defines a pituitary malignancy and the differences between benign and malignant tumors. What is an aggressive tumor and what makes it behave that way.
From Lewis S Blevins, Jr. MD – I recently addressed a question regarding normal oral glucose suppression test results in a patient who reportedly looked as if they had acromegaly. I wanted to share my
In this podcast, Dr. Lewis Blevins and Jorge Faccinetti discuss the highlights of the conference held in San Francisco in late October. The program focused on the latest updates and recent advances regarding pituitary tumors
From J D Faccinetti, Pituitary World News co-founder – One of the few things that positively drives me absolutely bananas is the increased belly fat that I experienced post surgery, and that later learned is
From J D Faccinetti – Pituitary World News Co-founder – Technology could have a profound effect in the way acromegaly is diagnosed and hopefully prompt primary care doctors, dentist and other primary care health professionals
A recent article from the Endocrinology Department of “Escola Universitària d’Infermeria, Hospital Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain” explores health related quality of life (QoL) issues in patients with pituitary disease. The article
An acromegaly story all the way from Patagonia, Argentina From J D Faccinetti – Pituitary World News co-founder – Carol Mackie Passera (Passera is her married name) is my second cousin. Our maternal grandmothers were
In part 2 of our series on Acromegaly Dr. Blevins deals with Dopamine Agonists, a class of drugs used in the treatment of acromegaly. Stay tuned for part 3 in the series coming up very